Koios Care
Overview
Koios Care is a health technology company based in Antwerp, Belgium, focused on improving the quality of life for individuals with neurological and chronic conditions, particularly Parkinson's Disease. Founded in 2022 by Dr. Konstantinos Kyritsis and Dr. Dimitris Iakovakis, the company recently secured €1 million in funding to expand its platform and enhance patient care through AI-powered tools. The company's innovative approach includes using everyday devices like smartphones and smartwatches to generate real-world data to assist clinical decision-making.
Recent Developments
- June 2025: Koios Care secured €1 million in seed funding led by Evercurious VC. The funds are earmarked for expanding the company's digital health tool "Parkiwatch" across European clinics, as well as supporting regulatory clearance efforts (source).
- June 2025: The company demonstrated the scalability of its platform through a multi-center study involving 130 patients, aiming to personalize Parkinson's Disease care and improve patient outcomes (source).
- June 2025: Officials from Evercurious VC highlighted the significance of Koios Care's use of passive monitoring through everyday devices, praising its scientific rigor and potential to reshape care for neurodegenerative disorders (source).
- June 2025: With plans to expand its technology to other conditions like Alzheimer's and narcolepsy, Koios Care is poised for growth in areas where continuous, real-world monitoring can fill critical gaps (source).
Company Information
| Attribute | Information |
|---|---|
| Founding Date | 2022 |
| Headquarters | Antwerp, Belgium |
| Founders | Dr. Konstantinos Kyritsis, Dr. Dimitris Iakovakis |
| Revenue | Not publicized |
| Key Investors | Evercurious VC, Astylab Ventures, imec.istart |
| Industry | Digital Health, Neurology |
| Number of Employees | 2-10 |
Early History
Founded in 2022 by Dr. Konstantinos Kyritsis and Dr. Dimitris Iakovakis, Koios Care emerged as an innovative player in the digital health landscape. The company was built with a mission to improve neurological care by leveraging passive data collection from everyday devices to generate actionable clinical insights. With their first products focused on Parkinson’s Disease, the founders recognized a critical gap in current healthcare models, which often lacked continuous, objective data to personalize care. Initial funding efforts included participation by key stakeholders like imec.istart, establishing a foundation for rapid growth and development in real-time health monitoring technologies.
Company Profile and Achievements
Koios Care operates within the burgeoning digital health sector, focusing on the integration of AI-driven insights into neurological care. The company's business model offers dual services:
- For Patients and Care Providers: Koios Care provides a comprehensive digital tool that supports quality of life improvement and streamlines treatment decisions based on real-world evidence.
- For Pharmaceutical and MedTech Companies: It offers a valuable R&D platform that accelerates therapeutic development through precise, data-driven evidence generation. Significant achievements include:
- Development of the Parkiwatch platform, which seamlessly integrates passive data collection from wearables to provide critical insights into patient health.
- Completion of substantial clinical trials that have validated the efficacy of their platform, involving 130 patients across European institutions.
- Established partnerships with key players in the healthtech space and secured substantial investment from Evercurious VC and others.
Current Operations and Market Position
Koios Care continues to enhance its presence in the digital health market by focusing on augmenting its AI-based diagnostic tools. It is a potent force for innovation in neurodegenerative disease management, providing a bridge between real-world patient data and clinical care solutions. While existing health systems rely heavily on episodic data capture, Koios Care’s platform supports continuous, proactive health management, potentially improving patient outcomes significantly. The company’s strategic initiatives include further expansion into other neurological conditions, highlighting its adaptability and foresight in addressing a broad spectrum of healthcare needs.
Conclusion
Koios Care stands as a beacon of innovation within the digital health sector, particularly for managing neurodegenerative diseases like Parkinson's. By leveraging cutting-edge AI technologies and real-time data collection from everyday devices, it provides a scalable solution that bridges the gap between clinical needs and available therapeutic interventions. As the firm continues to expand its services and technological capabilities, it is poised to set transformative precedents in personalized healthcare, significantly impacting patient care and outcomes across Europe and beyond.